cardiology
ORBIT Bleeding Risk Score for Anticoagulation in AF Patients
ORBIT (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) bleeding risk score for predicting major bleeding during anticoagulation for atrial fibrillation. Validated in over 7,400 AF patients.
References
- O'Brien EC et al. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation. Eur Heart J. 2015;36(46):3258-3264.
- NICE NG196. Atrial fibrillation: diagnosis and management. NICE. 2021.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Edoxaban (AF Stroke Prevention / VTE) · Direct Factor Xa Inhibitor (DOAC)
- Betrixaban (Extended VTE Prophylaxis — Medical Patients) · Oral Factor Xa Inhibitor (DOAC — Extended Duration)
- Bivalirudin (PCI Anticoagulation) · Direct Thrombin Inhibitor / PCI
- Vernakalant · Atrial-selective antiarrhythmic
- Aspirin (Loading Dose) · Antiplatelet — ACS / Ischaemic Stroke
- Alteplase (tPA) · Thrombolytic — Ischaemic Stroke / Massive PE
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.